In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Protecting Device Innovation: An Interview With Tom Fogarty

This article was originally published in Start Up

Executive Summary

Noted physician/entrepreneur Tom Fogarty has long been known for inventing breakthrough new products, but here he discusses his recent efforts focused on working to protect the medical device innovation model and correct what he sees as serious flaws that may hinder its long-term viability, especially in the US.

You may also be interested in...



HeartFlow: Disrupting The Diagnostic Paradigm In Cardiology

Most current cardiac diagnostic imaging tests are highly inexact, relying heavily on clinicians' observations. HeartFlow is adapting advanced computer modeling to cardiology to produce a precise, predictive, noninvasive diagnostic that doubles as a treatment planning tool. The test could eliminate unnecessary procedures for patients and save the system money, but is that what interventionalists want?

The Fogarty Institute For Innovation: A Device Incubator For Difficult Times

Go to any gathering of medical device start-up CEOs and their investors, and beneath a veneer of passionate intensity about individual technology lie concern, anxiety, and in some cases, real pessimism. Central to the debate: is the device innovation model broken? Six years ago, one of the most celebrated device entrepreneurs, Tom Fogarty, MD, working with officials at El Camino Hospital in Mountain View, CA, an independent community hospital located in the heart of the San Francisco device community, launched the Fogarty Institute for Innovation, an initiative designed to help the earliest-stage companies ramp up technology development quickly and efficiently in an effort to minimize, if not eliminate the external challenges. To date, the Institute has started or nurtured five companies.

Back Behind the Inventor's Bench: An Interview with Tom Fogarty

The dean of device physician-entrepreneurs is launching a new crop of start-ups. Here Thomas Fogarty, MD, a cardiovascular surgeon and the entrepreneur behind more than 30 device companies, talks about the current key issues in device company creation.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel